- Absorbable Dermal Fillers
- Non-Absorbable Dermal Fillers
UK Dermal Fillers Market size was valued at USD 54.3 million in 2021 and is expected to reach USD 81.0 million by 2028, at a CAGR of 8.2% during 2022-2028. Dermal fillers are the more convenient and comparatively less painful methods for the issues related to skin and especially facial skin. Due to its non-invasive nature coupled with the growth in popularity for the dermal fillers and volumizers among the youth population in UK expected to positively impact market growth in coming years. In no other area of aesthetics do practitioners have so many different products or treatment options available to them as dermal fillers. The growing adoption of invasive cosmetic procedures in the UK, and the absence of a coherent regulatory framework governing their use, received high levels of public attention in 2013 with the publication of the ‘Keogh report. According to a survey conducted by Whatclinic.com, there was a 24% increase in inquiries about dermal fillers from only 2015 to 2016. Furthermore, procedures are gaining traction due to their affordability and non-invasiveness. According to The British Association of Aesthetic Plastic Surgeons (BAAPS), the number of British citizens undergoing cosmetic surgery fell in 2016 to the lowest number in a decade, while non-surgical cosmetic treatments continue to rise. This report studies UK dermal fillers market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the market report includes information on distributors' influence on customer product choice, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition along with company share analysis. Moreover, PBI analyzed UK dermal fillers market to better equip clients with possible investment opportunities and market unmet needs (Product Opportunities).
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Growing concerns about quality of dermal filler products and methods of non-invasive procedures coupled with highly unregulated environment may impact the market revenue growth negatively. According to the results of a poll by WhatClinic.com, 42% of web traffic to lip augmentation pages were from visitors aged 18-24, with the clinics surveyed saying that while they unanimously would not provide lip filler to under 18s, most would provide fillers to under 21s. One of the biggest technological challenges facing the market is previous failures in the collection and handling of data in the industry. The industry already lacks comprehensive data on customers’ experiences after treatment amongst other things, and there continues to be cause to believe that problems with treatments after they have been carried out are severely underreported.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1. Executive summary |
2. UK Dermal Fillers Market Introduction |
2.1. UK Dermal Fillers Market – Taxonomy |
2.2. UK Dermal Fillers Market –Definitions |
2.2.1. By Ingredient Type |
2.2.2. By Product Type |
2.2.3. By Application Type |
2.2.4. By Distribution Channel |
3. UK Dermal Fillers Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. UK Dermal Fillers Market Dynamics – Factors Impact Analysis |
3.6. Distributors Influence on the purchase of the buyers |
3.7. UK Dermal Fillers Market Analysis, 2017 - 2021 and Forecast, 2022 – 2028 |
3.8. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
3.9. Year-over-Year (Y-o-Y) Growth Analysis (%) |
3.10. Market Opportunity Analysis |
3.11. UK Dermal Fillers Market, By Ingredient Type, 2017 - 2021 and Forecast, 2017 - 2023 |
3.12. Hyaluronic Acid |
3.12.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
3.12.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
3.12.3. Market Opportunity Analysis |
3.13. Poly-L-Lactic Acid (PLA) |
3.13.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
3.13.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
3.13.3. Market Opportunity Analysis |
3.14. Calcium Hydroxyapatite (CaH) |
3.14.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
3.14.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
3.14.3. Market Opportunity Analysis |
3.15. Polymethylmethacrylate (PMMA) |
3.15.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
3.15.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
3.15.3. Market Opportunity Analysis |
3.16. Collagen |
3.16.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
3.16.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
3.16.3. Market Opportunity Analysis |
4. UK Dermal Fillers Market, By Product Type, 2017 - 2021 and Forecast, 2017 - 2023 |
4.1. Absorbable Dermal Fillers |
4.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
4.1.3. Market Opportunity Analysis |
4.2. Non-Absorbable Dermal Fillers |
4.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5. UK Dermal Fillers Market Forecast, By Application Type, 2017 - 2021 and Forecast, 2022 – 2028 |
5.1. Aesthetic Reduction |
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Wrinkle Reduction |
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Dentistry |
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Reconstructive Surgery |
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6. UK Dermal Fillers Market Forecast, By Distribution Channel Type, 2017 - 2021 and Forecast, 2022 – 2028 |
6.1. Retail Pharmacies |
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Drug Stores |
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Beauty Clinics |
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. UK Dermal Fillers Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
7.1. By Ingredient Type Analysis (2012 – 2016) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
7.1.1. Hyaluronic Acid |
7.1.2. Poly-L-Lactic Acid (PLA) |
7.1.3. Calcium Hydroxyapatite (CaH) |
7.1.4. Polymethylmethacrylate (PMMA) |
7.1.5. Collagen |
7.2. By Product Type Analysis (2012 – 2016) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
7.2.1. Absorbable Dermal Fillers |
7.2.2. Non-Absorbable Dermal Fillers Blood |
7.3. Application Type Analysis (2012 – 2016) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
7.3.1. Aesthetic Reduction |
7.3.2. Wrinkle Reduction |
7.3.3. Dentistry |
7.3.4. Reconstructive Surgery |
7.4. Distribution Channel Analysis (2012 – 2016) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
7.4.1. Retail Pharmacies |
7.4.2. Drug Stores |
7.4.3. Beauty Clinics |
7.4.4. Others |
7.5. UK Dermal Fillers Market - Opportunity Analysis Index, By Ingredient Type, By Product Type, By Application Type, and By Distribution Channel, 2022 – 2028 |
7.6. UK Dermal Fillers Market Dynamics – Trends |
7.7. Competition Landscape |
7.8. Strategic Dashboard of Top Market Players |
7.9. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
7.9.1. Galderma (Nestle) |
7.9.2. Merz Pharma GmbH & Co. KGaA |
7.9.3. Allergan |
7.9.4. ADODERM GmbH |
7.9.5. Syneron |
7.9.6. Suneva Medical |
7.9.7. Sinclair Pharma |
7.9.8. Fidia Pharma |
8. Research Methodology |
9. Key Assumptions and Acronyms |